Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Survival Tree01:19

Survival Tree

374
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
374
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

537
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
537

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newly Identified Genetic Associations of Alzheimer Disease by Conditional Selective Inference: Potential Implications for the Tau Hypothesis.

Bioinformatics and biology insights·2025
Same author

Integrative pathway analysis with gene expression, miRNA, methylation and copy number variation for breast cancer subtypes.

Statistical applications in genetics and molecular biology·2024
Same author

KARR-seq reveals cellular higher-order RNA structures and RNA-RNA interactions.

Nature biotechnology·2024
Same author

Rapamycin-Induced Feedback Activation of eIF4E-EIF4A Dependent mRNA Translation in Pancreatic Cancer.

Cancers·2023
Same author

Deciphering the role of RNA structure in translation efficiency.

BMC bioinformatics·2022
Same author

Translocation detection from Hi-C data via scan statistics.

Biometrics·2022

Related Experiment Video

Updated: Jan 9, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Unsupervised Random Forest Identifies Important Genetic Prognostic Factors for Breast Cancer Survival Time.

Benjamin Goldberg1, Eric Nels Pederson1, Zhengqing Ouyang1

  • 1Department of Biostatistics & Epidemiology, School of Public Health & Health Sciences, University of Massachusetts Amherst, USA.

Cancer Informatics
|December 1, 2025
PubMed
Summary
This summary is machine-generated.

This study identifies key genes influencing breast cancer prognosis using advanced random forest modeling. The findings confirm known prognostic genes and highlight three novel candidates for further investigation.

Keywords:
cluster analysiscomputational modelsgene expressionsurvival analysisunsupervised learning

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

628

Related Experiment Videos

Last Updated: Jan 9, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

628

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Breast cancer prognosis is highly variable and influenced by gene expression.
  • Identifying prognostic genes is crucial for clinical tests and understanding disease biology.
  • Prior efforts have focused on gene identification, but powerful statistical methods can enhance discovery.

Purpose of the Study:

  • To identify genes critical for breast cancer prognosis using advanced statistical methods.
  • To improve the understanding of breast cancer biology through gene expression analysis.
  • To evaluate the effectiveness of unsupervised random forest models in prognostic gene identification.

Main Methods:

  • Utilized an unsupervised random forest model for non-linear gene expression/survival analysis.
  • Analyzed data from 1,518 participants in the METABRIC dataset.
  • Included 20,387 mRNA expression variables and 23 clinical variables, including HER2 status.

Main Results:

  • Confirmed 27 previously identified prognostic genes.
  • Identified 3 potentially novel prognostic genes.
  • Gene ontology analysis suggested plausible biological connections for the novel genes.

Conclusions:

  • The unsupervised random forest model is effective for identifying prognostic genes in breast cancer.
  • The identified genes, particularly the novel ones, warrant experimental investigation.
  • This approach enhances the discovery of genes impacting breast cancer outcomes.